Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From NBTY Inc.

Supplement Industry Investment Continues On Swander Pace Contract Manufacturing Move

Swander Pace expands Captek’s operations less than two years after acquiring the firm and seven months after investing in a protein supplement manufacturer as one of numerous private equity firms active in the nutritional products space.

Dietary Supplements Financing

Carlyle Trims Nature's Bounty Assets: Private Equity Rolls In Supplement Space

Carlyle's $2.2bn sale of Nature's Bounty's Holland & Barrett business to a Russian investment fund is the latest sign of the private equity sector's continuing interest in the health and wellness space.

Dietary Supplements M & A

Consensus-Based Supplement GMP Standards In Fine-Tuning Phase

ANSI-approved, consensus-based standards for supplement GMPs set to debut in early 2017 should help reduce the overall number of audits required for the category, says the Global Retailer and Manufacturer Alliance, which has worked since 2014 to develop the standard.

United States Dietary Supplements

Nature's Bounty Returns To Top Billing As NBTY's New Name

The firm owned since 2010 by a Carlyle Group holding company opts for a name that encompasses its largest brand, which also had been its name until the previous management chose the name NBTY in 1995.

United States Companies
See All
UsernamePublicRestriction

Register